Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study

PURPOSE: Capecitabine, an oral fluorouracil (5-FU) derivative, has replaced 5-FU in many chemotherapy regimens used in various GI tract cancers. The experience with capecitabine in nasopharyngeal carcinoma (NPC) is limited. PATIENTS AND METHODS: We report on eight patients with locally advanced NPC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Glob Oncol
Hlavní autoři: Dada, Reyad, El Sayed, Mohamed, Zekri, Jamal
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2016
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646894/
https://ncbi.nlm.nih.gov/pubmed/29094083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2016.006924
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky